Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) Long-Term Deferred Tax (2024 - 2025)

Updated

Odyssey Therapeutics (ODTX) posted Long-Term Deferred Tax of $5,098 for Q4 2025, down 40.0% from $8,500 a year earlier.

Analysis

Odyssey Therapeutics (ODTX) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends

  • In prior years, Odyssey Therapeutics' Long-Term Deferred Tax was $8,500 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 5,098.00
Dec 31, 2024 8,500.00
API Access

Odyssey Therapeutics Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=ODTX&period=max&api_key=YOUR_API_KEY